BioAlps and ISS AG, Integrated Scientific Service in collaboration with the Swiss Biotech Association and the Swiss Chemical Society organise a Medtech symposium on Thursday 8 October to provide information to Medtech companies regarding the CE-marking process, specifically within the new EU MDR which has been postponed to May 2021 due to Covid-19.

In the form of a round-table, punctuated by each topic flash introduction to bring everybody on the same floor, Swiss Industry experts will share their experience and recommendation to cope with the new requirements and timelines. Among other topics, the challenges regarding the establishment of a product registration strategy in such a context, the business impact of MDR, the lack of qualified resources and the generation of clinical data will be addressed at the round-table.

The event is announced here.

Free registration and more general information, including covid protection concept: www.ilmac.ch.